Dosimetric effect of interfractional needle displacement in prostate high-dose-rate brachytherapy

Brachytherapy

Volumn 11, Issue 2, 2012, Pages 111-118

  Kovalchuk, Nataliya ^a   Furutani, Keith M ^a   MacDonald, O Kenneth ^a   Pisansky, Thomas M ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Dosimetry; HDR brachytherapy; Needle displacement; Prostate

Indexed keywords

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; PROSTATE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; URETHRA;

BRACHYTHERAPY; HUMANS; MALE; NEEDLES; PROSTATE; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84857796516     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2011.05.006     Document Type: Article

References (11)

1. Damore S.J., Syed A.M.N., Puthawala A.A., et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2000, 46:1205-1211.
2. Hoskin P.J., Bownes P.J., Ostler P., et al. High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions. Radiother Oncol 2003, 68:285-288.
3. Kim Y., Hsu I.C., Lessard E., et al. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys 2004, 59:1208-1216.
4. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 2001, 49:61-69.
5. Mullokandov E., Gejerman G. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys 2004, 58:1063-1071.
6. Simnor T., Li S., Lowe G., et al. Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer. Radiother Oncol 2009, 93:253-258.
7. Tiong A., Bydder S., Ebert M., et al. A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible. Int J Radiat Oncol Biol Phys 2010, 76:1066-1072.
8. Yoshida K., Yamazaki H., Nose T., et al. Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. Brachytherapy 2009, 9:36-41.
9. Fiorino C., Reni M., Bolognesi A., et al. Intra- and inter-observer variability in contouring prostate and seminal vesicles: Implications for conformal treatment planning. Radiother Oncol 1998, 47:285-292.
10. Dubois D., Prestidge B., Hotchkiss L.A., et al. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology 1998, 207:785-789.
11. Call J, Pisansky T, Choo CR, et al. High dose rate (HDR) brachytherapy as monotherapy for localized prostate cancer: Correlation of early adverse events (AEs) and dose. Proceedings of RSNA, Chicago, IL; 2009 Nov 29-Dec 4.